Overview of Clinical Research in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Overview of Clinical Research in Brazil

Overview of Clinical Research in Brazil – CRO Partner

Clinical research stands as the cornerstone of medical progress, facilitating the discovery of innovative treatments, therapies, and medical interventions. In this pursuit, Brazil has emerged as a prominent player in the global clinical research arena.

With its vast landscapes, rich culture, and diverse population, Brazil’s contribution to clinical research holds immense significance. This blog provides a comprehensive overview of clinical research in Brazil, delving into its importance, regulatory framework, key players, challenges, and the transformative impact it has on healthcare.

The Significance of Clinical Research in Brazil

Clinical research plays a pivotal role in Brazil due to several compelling reasons:

  1. Diverse Healthcare Challenges: Brazil faces a wide spectrum of healthcare challenges, from infectious diseases to chronic conditions. Clinical research serves as a catalyst for addressing these challenges by identifying effective treatments and interventions that are tailored to the unique healthcare landscape.
  2. Population Diversity: Brazil boasts a diverse population with a blend of ethnicities and genetic backgrounds. This diversity provides researchers with a unique opportunity to study genetic predispositions, treatment responses, and the interaction between genetics and diseases.
  3. Global Collaborations: International pharmaceutical companies and research institutions recognize Brazil’s potential as a clinical research hub. Collaborative efforts between local and global researchers foster the acceleration of medical breakthroughs and the exchange of valuable knowledge.

The Regulatory Framework

Clinical research in Brazil operates within a regulatory framework overseen by the Brazilian Health Regulatory Agency (ANVISA) and the National Research Ethics Committee (CONEP). These regulations ensure the ethical treatment of participants, data integrity, and adherence to safety standards. Key elements of the regulatory framework include:

  1. Ethical Oversight: Clinical trials in Brazil must undergo rigorous ethical review by Institutional Review Boards (IRBs) to safeguard participant rights, well-being, and safety.
  2. Informed Consent: Obtaining informed consent from participants is a fundamental aspect of clinical research in Brazil. Participants must be fully informed about the study’s objectives, procedures, potential risks, and benefits before agreeing to participate.

Data Protection: Stringent data protection measures are enforced to uphold the confidentiality and privacy of participants’ personal and medical information, aligning with international data privacy standards.

Overview of Clinical Research in Brazil

Overview of Clinical Research in Brazil

Overview of Clinical Research in Brazil

Key Contributors in Brazilian Clinical Research

Numerous stakeholders contribute to the dynamic clinical research landscape in Brazil:

  1. Academic and Medical Institutions: Universities and research hospitals are instrumental in conducting clinical trials, fostering a culture of innovation and knowledge dissemination.
  2. Pharmaceutical Companies: Both domestic and international pharmaceutical companies conduct trials to evaluate the safety and efficacy of new drugs, therapies, and medical devices.
  3. Contract Research Organizations (CROs): CROs play a critical role in overseeing clinical trials on behalf of pharmaceutical companies, ensuring adherence to regulations and the efficient execution of trials.
  4. Government Entities: ANVISA and CONEP provide regulatory oversight, review research protocols, and enforce ethical standards.

Challenges and Future Outlook

While Brazilian clinical research has made significant strides, it also faces certain challenges:

  1. Regulatory Complexity: Navigating the regulatory landscape can be intricate, potentially deterring researchers and sponsors from conducting trials in the country.
  2. Infrastructure Disparities: While urban areas have advanced medical facilities, rural regions may lack the necessary infrastructure, affecting equitable access to research opportunities.
  3. Public Awareness: Limited public awareness about the benefits and importance of clinical trials can lead to skepticism and reluctance to participate.

Looking ahead, the future of clinical research in Brazil is promising:

  1. Streamlined Regulations: Simplifying regulatory procedures can attract increased international collaboration and investment, bolstering clinical research activities.
  2. Capacity Building: Continued investment in training healthcare professionals and researchers will enhance Brazil’s ability to conduct high-quality trials.
  3. Community Engagement: Enhancing public awareness and involving communities in research planning can foster trust and encourage greater participation in clinical trials.


Brazil’s clinical research landscape is a dynamic realm with the potential to drive medical advancements and elevate patient care on a global scale. With its diverse population, robust regulatory framework, and collaborative network of stakeholders, Brazil is poised to make substantial contributions to global healthcare through its participation in clinical research.

As the nation addresses challenges and builds on its strengths, the future of clinical research in Brazil holds a promising blend of innovation, collaboration, and improved health outcomes.

Overview of Clinical Research in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Overview of Clinical Research in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Overview of Clinical Research in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Overview of Clinical Research in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Overview of Clinical Research in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Overview of Clinical Research in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Overview of Clinical Research in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Overview of Clinical Research in Brazil

The Cohortias Team

Overview of Clinical Research in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Overview of Clinical Research in Brazil

Network & Partnerships